13D/13G Filings - Xenetic Biosciences Inc. (XBIO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-03-18
1:45 pm
Purchase
2024-03-1813DXenetic Biosciences, Inc.
XBIO
CLS Therapeutics LLC215,964
14.000%
17,076increase
(+8.59%)
Filing
History
2023-09-18
12:21 pm
Purchase
2023-09-0513DXenetic Biosciences, Inc.
XBIO
CLS Therapeutics LLC198,888
13.000%
51,388increase
(+34.84%)
Filing
History
2023-06-15
5:20 pm
Sale
2023-06-1413DXenetic Biosciences, Inc.
XBIO
CLS Therapeutics LLC147,500
9.700%
-0decrease
(-0.00%)
Filing
History
2022-10-21
4:19 pm
Purchase
2022-10-1213GXenetic Biosciences, Inc.
XBIO
CLS Therapeutics LLC147,500
9.700%
147,500increase
(New Position)
Filing
History
2020-12-21
06:20 am
Unchanged
2020-12-1013GXenetic Biosciences, Inc.
XBIO
Mitchell P. Kopin0
0.000%
0
(Unchanged)
Filing
History